Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Cough Remedies Market

Cough Remedies Market Share

Report ID: GMI9224
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Cough Remedies Market Share

The cough remedies industry is characterized by the presence of several key players offering range of products spanning across different dosage and medication categories. Investments related to research and developments of products, strategic partnerships, mergers, and acquisitions are among the commonly employed strategies by players to expand their market presence and gain a competitive advantage.

Cough Remedies Market Companies

Prominent players operating in the cough remedies industry include:

AstraZeneca plc
Bayer AG
GSK plc
Johnson & Johnson
Novartis AG
Pfizer Inc.
Prestige Consumer Healthcare
Procter & Gamble
Reckitt Benckiser Group plc
Sun Pharmaceutical Industries Ltd

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cough remedies reached USD 9.2 billion in 2023 and is set to witness 5.6% CAGR from 2024 to 2032, owing to growing prevalence of respiratory conditions and increasing air pollution levels.

The oral syrups segment accounted for 45.4% of the market share in 2023, due to personal preferences or ease of use.

North America market size was USD 3.4 billion in 2023 and is anticipated to grow at 5.1% CAGR between 2024

AstraZeneca plc, Bayer AG, GSK plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Prestige Consumer Healthcare, Procter & Gamble, Reckitt Benckiser Group plc and Sun Pharmaceutical Industries Ltd.